Concepts (158)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes, Gestational | 6 | 2025 | 140 | 4.120 |
Why?
|
| Pregnancy Complications, Cardiovascular | 4 | 2025 | 36 | 2.670 |
Why?
|
| Pregnancy | 28 | 2025 | 2335 | 2.610 |
Why?
|
| Pre-Eclampsia | 4 | 2024 | 71 | 2.290 |
Why?
|
| Cesarean Section | 4 | 2024 | 101 | 1.780 |
Why?
|
| Hypoglycemia | 2 | 2023 | 65 | 1.470 |
Why?
|
| Prediabetic State | 2 | 2022 | 53 | 1.440 |
Why?
|
| Glucose Intolerance | 2 | 2022 | 90 | 1.400 |
Why?
|
| Retrospective Studies | 20 | 2025 | 6673 | 1.340 |
Why?
|
| Obstetric Labor Complications | 2 | 2021 | 23 | 1.300 |
Why?
|
| Infant, Newborn | 11 | 2025 | 1358 | 1.290 |
Why?
|
| Arrhythmias, Cardiac | 3 | 2025 | 153 | 1.220 |
Why?
|
| Hypertension, Pregnancy-Induced | 3 | 2025 | 40 | 1.210 |
Why?
|
| Hypoglycemic Agents | 3 | 2025 | 220 | 1.110 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2023 | 621 | 1.080 |
Why?
|
| Female | 32 | 2025 | 32912 | 1.040 |
Why?
|
| Ebstein Anomaly | 1 | 2025 | 5 | 0.950 |
Why?
|
| Pregnancy Outcome | 5 | 2025 | 194 | 0.910 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2023 | 697 | 0.910 |
Why?
|
| Labor, Obstetric | 2 | 2023 | 37 | 0.880 |
Why?
|
| Heart Diseases | 2 | 2024 | 218 | 0.860 |
Why?
|
| Metformin | 1 | 2025 | 74 | 0.850 |
Why?
|
| Stillbirth | 1 | 2023 | 17 | 0.840 |
Why?
|
| Labor Presentation | 1 | 2023 | 3 | 0.820 |
Why?
|
| Prenatal Diagnosis | 1 | 2023 | 40 | 0.820 |
Why?
|
| Aneuploidy | 1 | 2023 | 42 | 0.810 |
Why?
|
| Dyspnea | 1 | 2024 | 124 | 0.810 |
Why?
|
| Cervical Ripening | 1 | 2023 | 11 | 0.810 |
Why?
|
| Chorioamnionitis | 2 | 2023 | 14 | 0.800 |
Why?
|
| Labor, Induced | 1 | 2023 | 25 | 0.790 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2023 | 62 | 0.790 |
Why?
|
| Genetic Testing | 1 | 2023 | 134 | 0.780 |
Why?
|
| Heart Failure | 3 | 2025 | 914 | 0.760 |
Why?
|
| Pregnancy in Diabetics | 1 | 2021 | 10 | 0.740 |
Why?
|
| Mitral Valve Prolapse | 1 | 2021 | 11 | 0.730 |
Why?
|
| Postpartum Period | 3 | 2023 | 195 | 0.730 |
Why?
|
| Insulins | 1 | 2021 | 15 | 0.720 |
Why?
|
| Humans | 32 | 2025 | 63511 | 0.720 |
Why?
|
| Hysterotomy | 1 | 2021 | 1 | 0.700 |
Why?
|
| Vagina | 2 | 2018 | 83 | 0.700 |
Why?
|
| Uterine Rupture | 1 | 2021 | 6 | 0.700 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2023 | 133 | 0.700 |
Why?
|
| Echocardiography | 1 | 2024 | 502 | 0.680 |
Why?
|
| Blood Glucose | 4 | 2023 | 484 | 0.650 |
Why?
|
| Adult | 17 | 2025 | 16837 | 0.640 |
Why?
|
| Vaginal Neoplasms | 1 | 2018 | 3 | 0.600 |
Why?
|
| Lacerations | 1 | 2018 | 15 | 0.590 |
Why?
|
| Perineum | 1 | 2018 | 19 | 0.590 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2018 | 16 | 0.590 |
Why?
|
| Menorrhagia | 1 | 2018 | 18 | 0.580 |
Why?
|
| Rejuvenation | 1 | 2018 | 3 | 0.580 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2019 | 65 | 0.580 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2019 | 92 | 0.570 |
Why?
|
| Bacteremia | 1 | 2019 | 94 | 0.560 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2018 | 47 | 0.560 |
Why?
|
| Burkitt Lymphoma | 1 | 2018 | 73 | 0.550 |
Why?
|
| Risk Factors | 7 | 2025 | 5359 | 0.510 |
Why?
|
| Pregnancy in Adolescence | 1 | 2016 | 21 | 0.500 |
Why?
|
| Pregnancy Rate | 1 | 2016 | 31 | 0.500 |
Why?
|
| Contraception Behavior | 1 | 2016 | 37 | 0.480 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 837 | 0.470 |
Why?
|
| Logistic Models | 4 | 2024 | 1276 | 0.460 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 790 | 0.450 |
Why?
|
| United States | 7 | 2025 | 7852 | 0.450 |
Why?
|
| Peripartum Period | 2 | 2024 | 21 | 0.360 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 378 | 0.360 |
Why?
|
| Parturition | 2 | 2021 | 55 | 0.350 |
Why?
|
| Glucose | 2 | 2023 | 467 | 0.320 |
Why?
|
| Parity | 2 | 2023 | 71 | 0.320 |
Why?
|
| Insulin | 2 | 2023 | 686 | 0.290 |
Why?
|
| Contraception | 2 | 2022 | 71 | 0.290 |
Why?
|
| Young Adult | 5 | 2025 | 4700 | 0.280 |
Why?
|
| Infant | 2 | 2023 | 1645 | 0.270 |
Why?
|
| Delivery, Obstetric | 2 | 2018 | 52 | 0.260 |
Why?
|
| Troponin I | 1 | 2025 | 35 | 0.240 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2025 | 55 | 0.230 |
Why?
|
| Adolescent | 4 | 2021 | 6248 | 0.220 |
Why?
|
| Pericardial Effusion | 1 | 2024 | 21 | 0.210 |
Why?
|
| Peptide Fragments | 1 | 2025 | 410 | 0.200 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2023 | 12 | 0.200 |
Why?
|
| Infusions, Intravenous | 1 | 2023 | 173 | 0.200 |
Why?
|
| Heart Defects, Congenital | 1 | 2024 | 103 | 0.200 |
Why?
|
| Heart Valve Diseases | 1 | 2024 | 95 | 0.200 |
Why?
|
| Endometrial Neoplasms | 1 | 2023 | 61 | 0.200 |
Why?
|
| Cohort Studies | 3 | 2024 | 2574 | 0.190 |
Why?
|
| Gestational Age | 1 | 2023 | 189 | 0.190 |
Why?
|
| Carbohydrates | 1 | 2022 | 40 | 0.190 |
Why?
|
| Contraceptive Effectiveness | 1 | 2022 | 3 | 0.190 |
Why?
|
| Acculturation | 1 | 2022 | 37 | 0.190 |
Why?
|
| Cardiomyopathies | 1 | 2024 | 125 | 0.190 |
Why?
|
| Antihypertensive Agents | 1 | 2023 | 169 | 0.180 |
Why?
|
| Early Diagnosis | 1 | 2021 | 99 | 0.180 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 179 | 0.180 |
Why?
|
| Trial of Labor | 1 | 2021 | 7 | 0.170 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2025 | 774 | 0.170 |
Why?
|
| Preconception Care | 1 | 2021 | 23 | 0.170 |
Why?
|
| Electrocardiography | 1 | 2024 | 554 | 0.170 |
Why?
|
| Hypertension | 1 | 2025 | 587 | 0.160 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 731 | 0.160 |
Why?
|
| Odds Ratio | 1 | 2021 | 768 | 0.160 |
Why?
|
| Heart Arrest | 1 | 2021 | 173 | 0.150 |
Why?
|
| Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2019 | 4 | 0.150 |
Why?
|
| Uterine Diseases | 1 | 2019 | 9 | 0.150 |
Why?
|
| Extraction, Obstetrical | 1 | 2018 | 1 | 0.150 |
Why?
|
| Episiotomy | 1 | 2018 | 2 | 0.150 |
Why?
|
| Puerperal Disorders | 1 | 2019 | 15 | 0.150 |
Why?
|
| Diet | 1 | 2022 | 527 | 0.150 |
Why?
|
| Fever | 1 | 2019 | 66 | 0.150 |
Why?
|
| Laparoscopy | 1 | 2023 | 495 | 0.150 |
Why?
|
| Pelvis | 1 | 2018 | 59 | 0.150 |
Why?
|
| Narcotics | 1 | 2018 | 58 | 0.140 |
Why?
|
| Counseling | 1 | 2021 | 362 | 0.140 |
Why?
|
| Surgery, Plastic | 1 | 2018 | 19 | 0.140 |
Why?
|
| Boston | 1 | 2018 | 253 | 0.140 |
Why?
|
| Prenatal Care | 1 | 2019 | 170 | 0.130 |
Why?
|
| Gravidity | 1 | 2016 | 12 | 0.130 |
Why?
|
| Arousal | 1 | 2016 | 42 | 0.120 |
Why?
|
| Evoked Potentials | 1 | 2016 | 39 | 0.120 |
Why?
|
| Ultrasonography | 1 | 2018 | 485 | 0.120 |
Why?
|
| Pattern Recognition, Visual | 1 | 2016 | 38 | 0.120 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 2578 | 0.120 |
Why?
|
| Abortion, Induced | 1 | 2016 | 27 | 0.120 |
Why?
|
| Prospective Studies | 2 | 2025 | 3301 | 0.120 |
Why?
|
| Exercise | 1 | 2022 | 942 | 0.120 |
Why?
|
| Brain Mapping | 1 | 2016 | 232 | 0.110 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 449 | 0.110 |
Why?
|
| Hospitalization | 1 | 2021 | 1364 | 0.110 |
Why?
|
| Emotions | 1 | 2016 | 223 | 0.100 |
Why?
|
| Obesity | 1 | 2021 | 1236 | 0.100 |
Why?
|
| Stroke | 1 | 2021 | 1196 | 0.090 |
Why?
|
| Inflammation | 1 | 2019 | 1147 | 0.090 |
Why?
|
| Case-Control Studies | 2 | 2025 | 1119 | 0.090 |
Why?
|
| Child | 1 | 2021 | 4528 | 0.090 |
Why?
|
| Abruptio Placentae | 1 | 2024 | 2 | 0.060 |
Why?
|
| Umbilical Arteries | 1 | 2024 | 9 | 0.060 |
Why?
|
| Blood Gas Analysis | 1 | 2024 | 34 | 0.060 |
Why?
|
| C-Reactive Protein | 1 | 2025 | 166 | 0.060 |
Why?
|
| Fetal Blood | 1 | 2024 | 73 | 0.060 |
Why?
|
| Operative Time | 1 | 2024 | 92 | 0.050 |
Why?
|
| ROC Curve | 1 | 2024 | 282 | 0.050 |
Why?
|
| Observational Studies as Topic | 1 | 2023 | 61 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2025 | 512 | 0.050 |
Why?
|
| Hysterectomy | 1 | 2023 | 69 | 0.050 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2023 | 129 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 346 | 0.040 |
Why?
|
| Healthcare Disparities | 1 | 2024 | 360 | 0.040 |
Why?
|
| Biomarkers | 1 | 2025 | 1409 | 0.040 |
Why?
|
| National Institute of Child Health and Human Development (U.S.) | 1 | 2019 | 5 | 0.040 |
Why?
|
| Decision Trees | 1 | 2019 | 51 | 0.040 |
Why?
|
| Time Factors | 1 | 2024 | 3770 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 1147 | 0.030 |
Why?
|
| Task Performance and Analysis | 1 | 2016 | 129 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2016 | 149 | 0.030 |
Why?
|
| Incidence | 1 | 2019 | 1380 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 724 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 1655 | 0.030 |
Why?
|
| Middle Aged | 1 | 2024 | 17644 | 0.020 |
Why?
|
| Male | 1 | 2016 | 29927 | 0.010 |
Why?
|